PubMed Health⌕ Search

Biomedical subjects

L J Peters

Publications and source records attributed to L J Peters.

At least 217 records · Page 12Linked to original sources

Inhibition of artificial and spontaneous lung metastases by preirradiation of abdomen--II. Target organ and mechanism.

We have previously reported that irradiation of the abdomen of mice before i.v. injection of both immunogenic and nonimmunogenic tumour cells is capable of suppressing their ability to form metastatic lung nodules in a time and dose-dependent fashion. Experiments with segmental exposure indicated the target organ to be located in the ventral half of the abdomen. The effect has now been shown positively to depend upon irradiation of the caecum, and can be abolished either by shielding the caecum from irradiation or by surgically removing it prior to irradiation. Further experiments have shown that the effect cannot be elicited in germ-free mice and that its magnitude is markedly reduced in animals given gut-sterilizing antibiotics. Split-dose irradiation only slightly reduced the magnitude of suppression, provided both doses were given within the time window of effectiveness of single doses. Tumour-growth retardation was observed and spontaneous lung metastases were also suppressed when tumour-bearing mice received abdominal irradiation 7 days after tumour cell transplantation into the leg. However, abdominal irradiation did not significantly reduce subsequent tumour transplantability by the s.c. or i.p. routes. The experimental data are consistent with a mechanism by which transmigration of enteric bacteria across the radiation-damaged mucous membrane of the caecum effectively results in an endogenous infusion of endotoxin.

Abdomen↗

Tumor radioresistance in clinical radiotherapy.

Tumor radioresistance in clinical radiotherapy implies failure to achieve loco-regional disease control with radiation doses producing an acceptable degree of morbidity. Such radioresistance may be a result of many different causes (biological and technical) which are reviewed in terms of possible remedial actions. Dose response relationships for human cancers suggest that in many sites, tumors are heterogenous with respect to their cure-limiting characteristics. The case is developed that unless the predominant cure-limiting factor can be predicted, little benefit may be seen in trails of new treatment strategies using heterogeneous tumor populations. The fundamental problem of clinical radioresistance is therefore perceived as the inability to predictively identify its cause in the individual patient.

Cell Line↗

Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships.

Clinical and experimental evidence for divergent changes in early and late radiation responses in normal tissues after changes in dose fractionation indicate a greater sensitivity of late responses to changes in dose per fraction. In experimental studies of the effect of dose per fraction on early and late isoeffects, a larger number-of-fractions exponent for the late responses is the rule. These findings imply that the shape of the dose-survival curve for the target cells whose depletion results in late effects is different from that for target cells for acute effects: as the dose increases the contribution to cell killing from accumulated sublethal injury, relative to killing from single hit events, increases more rapidly in the target cells for late effects. In other words, the survival curve for the target cells for late injury must be "curvier" than that for acute effects. Although such survival curve characteristics are independent of the survival curve model chosen to describe them, they would represent, in terms of the parameters of the linear quadratic model, S = e -alphaD-beta D2, a higher beta/alpha ratio for late effects. If the dose survival characteristics of tumor clonogens resemble those of the target cells in acutely responding normal tissues, and if late injury in normal tissues is dose-limiting, then a therapeutic gain would result from reducing the size of dose per fraction by hyperfractionation. Conversely, increasing the size of dose per fraction should reduce the therapeutic differential.

Dose-Response Relationship, Radiation↗

Biological bases for high RBE values for late effects of neutron irradiation.

The late effects of fractionated irradiation with neutrons have been relatively more severe than after x-irradiation. Reasons for the RBEn/x being higher for late than for acute effects may include: (1) Late effects are reduced more by fractionation of X ray doses than are acute effects, whereas, with neutrons, the fractionation response is the same in rapidly-and slowly-responding tissues; (2) Late-responding tissues are less "sensitized" (and are, therefore, relatively protected) by redistribution throughout the division cycle during a fractionated regimen than are acutely-responding tissues: since neutron responses are less affected by cell-cycle distribution than are X ray responses, the relative protection of slowly-responding tissues is less; (3) The target cells for late, but not acute injury, may repair potentially lethal damage after X ray, but not after neutron exposure. Thus, the dissociation of RBE values for acute and late injury reflects mainly the dissociation between acute and late responses to conventional fractionated X ray regimens and, from the point of view of complications of radiotherapy, we should not condemn neutrons but praise X rays. Since fractionation of neutron doses into increments equivalent to those used in X ray therapy does not provide a preferential sparing of slowly-responding tissues, it is reasonable to shorten the overall duration of neutron treatment to deliver the total dose tolerated by the relevant "late-effects" tissue(s) in the shortest time consistent with acceptable acute responses.

Animals↗

Reduction of pesticide exposure with protective clothing for applicators and mixers.

Systemic pesticide illness in agricultural workers may result from excessive dermal exposure to pesticides. Workers who apply and mix pesticides (applicators and mixers) are not at special risk. Both acute and chronic exposures can occur from spillage or by environmental contamination of clothing. Two exposure assessment studies were conducted of Central Florida citrus grove workers who applied ethion daily. Measuring the percentage of penetration of ethion through clothing and measuring the daily urinary excretion of diethyl phosphate (DEP) were the techniques used to assess the protection afforded by changing daily to freshly laundered 100% cotton coveralls. Coveralls provided significantly greater protection than did regular clothing and the use of respirators.

Agricultural Workers' Diseases↗

Abdominal pregnancy in a golden hamster (Mesocricetus auratus).

Ten days following the birth of five apparently normal pups, a female hamster developed bilateral abdominal distention. Both dam and pups appeared healthy at this time. The dam was killed, and postmortem examination revealed five additional pups encapsulated in the abdominal cavity outside the uterus. It was not possible to determine if this was a primary ectopic implantation or occurred secondary to the recent partuition.

Animals↗

Mebendazole paste as an anthelmintic in random source research cats.

Mebendazole paste, administered per os daily for 3 days, at dose levels of 22 mg/kg and 33 mg/kg was highly effective in removing Ancylostoma tubaeforme from naturally infected cats. The 22 mg/kg dose gave the highest efficacy (95.5% critical and 98% controlled). The same product at 11 mg/kg, 22 mg/kg, or 33 mg/kg was 100% effective in removing Toxocara cati from naturally infected cats. Both 11 mg/kg and 22 mg/kg dose levels were highly efficacious against the common tapeworm, Dipylidium caninum. No toxic side effects or clinical illness were observed in any of the cats used in this study.

Animals↗

Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy.

From 1948 to 1972, 69 patients with inflammatory carcinoma of the breast were treated with irradiation alone. Because of a 46% incidence of local-regional failure, twice daily fractionated irradiation was given in 1972 to 11 patients; a decrease in local-regional failures (27%) was achieved. From 1973 through December 1976, preirradiation multidrug chemotherapy was added to the twice daily fractionated irradiation of 31 patients. Analysis of all patients with a minimum two-year follow-up demonstrates that chemotherapy does not improve local-regional control or freedom from disease rates, but does delay appearance of distant metastases.

Antineoplastic Agents↗